Care pathways for patients with breast cancer

Pittathankal, Antony; Davidson, T.

doi:10.1002/tre.144

Cited by 8 publications

(6 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Coupled with this, women with breast cancer may adopt a more sedentary lifestyle during recovery which may be associated with the development and worsening of PF symptoms [ 8 ]. While current breast cancer treatment guidelines highlight the importance of providing support for sexual dysfunction after breast cancer, the screening and management of UI and FI do not appear in breast cancer pathways of care [ 9 , 10 ] and often go untreated in this population [ 11 ]. Therefore, it is important to understand the symptom burden of PF dysfunction in women with breast cancer in order to inform care.…”

Section: Introductionmentioning

confidence: 99%

Experiences of pelvic floor dysfunction and treatment in women with breast cancer: a qualitative study

Colombage

Lin

Soh

et al. 2022

Support Care Cancer

View full text Add to dashboard Cite

Purpose To explore the experiences of women with breast cancer and pelvic floor (PF) dysfunction and the perceived enablers and barriers to uptake of treatment for PF dysfunction during their recovery. Method Purposive sampling was used to recruit 30 women with a past diagnosis of breast cancer and PF dysfunction. Semi-structured interviews were conducted, and data were analysed inductively to identify new concepts in the experiences of PF dysfunction in women with breast cancer and deductively according to the capability, opportunity, motivation and behaviour (COM-B) framework to identify the enablers and barriers to the uptake of treatment for PF dysfunction in women with breast cancer. Results Participants were aged between 31 and 88 years, diagnosed with stages I–IV breast cancer and experienced either urinary incontinence (n = 24/30, 80%), faecal incontinence (n = 6/30, 20%) or sexual dysfunction (n = 20/30, 67%). They were either resigned to or bothered by their PF dysfunction; bother was exacerbated by embarrassment from experiencing PF symptoms in public. Barriers to accessing treatment for PF dysfunction included a lack of awareness about PF dysfunction following breast cancer treatments and health care professionals not focussing on the management of PF symptoms during cancer treatment. An enabler was their motivation to resume their normal pre-cancer lives. Conclusion Participants in this study reported that there needs to be more awareness about PF dysfunction in women undergoing treatment for breast cancer. They would like to receive information about PF dysfunction prior to starting cancer treatment, be screened for PF dysfunction during cancer treatment and be offered therapies for their PF dysfunction after primary cancer treatment. Therefore, a greater focus on managing PF symptoms by clinicians may be warranted in women with breast cancer.

show abstract

Section: Introductionmentioning

confidence: 99%

Experiences of pelvic floor dysfunction and treatment in women with breast cancer: a qualitative study

Colombage

Lin

Soh

et al. 2022

Support Care Cancer

View full text Add to dashboard Cite

show abstract

“…Furthermore, out of a maximum of 30 points, participants at the workshops scored more than 60% on the rubric used in grading competence for developing clinical pathways. Small group learning activities are usually effective for building interdisciplinary collaboration and working through complex tasks, such as developing clinical pathways [2]. Interestingly, majority of the course participants (63%) lacked exposure to online learning prior to the course.…”

Section: Discussionmentioning

confidence: 99%

Enhancing Nigerian Healthcare Providers Competence in Breast Cancer Clinical Pathway Development using Blended Learning Approach

Eguzo¹,

Akpanudo

Oluoha

et al. 2021

Asian Pac J Cancer Care

View full text Add to dashboard Cite

Purpose: Clinical pathways are a means of translating universal clinical guidelines into local protocols to inform clinical practice. This study aimed to evaluate the effectiveness of using a blended learning approach for providing instruction and building competency on the development of breast cancer clinical pathways, using the guidelines from the National Cancer Control Network (NCCN). Methods: A one-group pretest-post test design was used for this study. Participants included healthcare providers and students in Nigeria, who were recruited through social media and professional organizations. The intervention was an online course delivered through Google Classroom, followed by two-day workshops at three locations. Data collection involved pre and post-tests scores from the online course, self-reported evaluation, as well as objective grading of in-person group projects. Results: Over 400 individuals joined the online course while 90 participated in the in-person workshops. Most participants (259/408, 63%) had no prior experience with online education, with an average age of 27.46 (±9.25) years. Data analysis revealed significant increases in mean knowledge scores across all groups from pretest (M=12.76, SE = 0.60) to post test (M =17.25, SE =0.38) p<0.001. Self-reported evaluation showed higher scores regarding chemotherapy administration for blended learning participants. Objective competence scores in developing clinical pathways ranged from 63% to 87%, across three sites. Conclusion: Findings reveal that both an online course alongside in-person workshops can be effective strategies for improving the knowledge and competence respectively of healthcare professionals on clinical pathways development. Participants in the blended learning component demonstrated significantly greater improvement in self-reported confidence scores. We recommend further studies to compare the relative strengths and limitations of these strategies.

show abstract

“…Examples are from the National Institute for Health and Care Excellence (NICE) in the UK [109,110] and Cancer Council Australia [111]. A paper from the UK also gives a good example and emphasises the role that care pathways play with the MDT as the integral part of the system [112]. The UK was one of the first countries to establish the value of MDTs for a cancer type, and together with defined care pathways has been instrumental in addressing variations in outcomes among breast units and regions in the country.…”

Section: Pathwaysmentioning

confidence: 99%

The requirements of a specialist Breast Centre

Wilson

Marotti²,

Bianchi

et al. 2013

European Journal of Cancer

158

109

View full text Add to dashboard Cite

show abstract

Care pathways for patients with breast cancer

Abstract: Although the incidence of breast cancer is increasing in the UK, mortality is decreasing thanks to significant achievements in the organisation and delivery of breast cancer care, with multidisciplinary working at its centre. Copyright © 2010 Wiley Interface Ltd

Cited by 8 publications

References 7 publications

Experiences of pelvic floor dysfunction and treatment in women with breast cancer: a qualitative study

Experiences of pelvic floor dysfunction and treatment in women with breast cancer: a qualitative study

Enhancing Nigerian Healthcare Providers Competence in Breast Cancer Clinical Pathway Development using Blended Learning Approach

The requirements of a specialist Breast Centre

Contact Info

Product

Resources

About